Gain Therapeutics Inc (GANX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $46.31M
Last updated: Nov 17, 2026 at 11:06 AM ET
Gain Therapeutics Inc (GANX) Competitors
The companies most similar to Gain Therapeutics are Grace Therapeutics (GRCE), Plus Therapeutics (PSTV) and OS Therapies (OSTX). By market cap, Gain Therapeutics ranks 6th of the 13 companies on this page; Cognition Therapeutics (CGTX) is the largest at $64.65M.
Peer Comparison
GANX's ROIC of -170.5% is below the peer median of -51.9%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| Pliant Therapeutics Inc (PLRX) | $43.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $40.64M | 11.1x | 1.3x | 0.0% | -51.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Gain Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| Pliant Therapeutics Inc (PLRX) | Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops... | PLRX competitors |
Frequently Asked Questions About GANX
Who are Gain Therapeutics' main competitors?
The companies most similar to Gain Therapeutics include Grace Therapeutics (GRCE), Plus Therapeutics (PSTV), OS Therapies (OSTX), Telomir Pharmaceuticals, Inc. Common Stock (TELO) and ProMIS Neurosciences (PMN), listed from the closest match.
Who is Gain Therapeutics' biggest competitor?
Cognition Therapeutics (CGTX) is the largest of the similar companies at $64.65M; Grace Therapeutics (GRCE) is the closest match by business profile, size, sector and industry.
How does GANX stock compare with its competitors?
GANX's net margin is 0.0% against a peer median of 0.0%.
Which of Gain Therapeutics' competitors pays a higher dividend?
Gain Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Gain Therapeutics bigger than its competitors?
No. Gain Therapeutics is 6th by market cap among the 13 companies on this page; the largest is Cognition Therapeutics (CGTX) at $64.65M.
GANX pages: Overview, Earnings, Forecast, Financials, Competitors